O'Toole; Margot

Patent Applications and Registrations

Patent applications and USPTO patent grants for O'Toole; Margot.The latest application filed is for "methods of treating inflammatory disorders using anti-m-csf antibodies".

Company Profile

0.9.18

O'Toole; Margot - Newtonville MA US
O'Toole; Margot - Newton MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods of using antibodies against human IL-22 Grant 8,906,375 - Fouser , et al. December 9, 2	2014-12-09
Methods of Treating Inflammatory Disorders Using Anti-M-CSF Antibodies App 20140286959 - Hegen; Martin ; et al.	2014-09-25
Methods Of Treatment Utiliziing Binding Proteins Of The Interleukin-21 Receptor App 20120276102 - BLOOM; Laird ; et al.	2012-11-01
Methods of treatment utilizing binding proteins of the interleukin-21 receptor Grant 8,178,097 - Bloom , et al. May 15, 2	2012-05-15
Methods Of Modulating Il-22 And Il-17 App 20110212099 - LIANG; Spencer C. ; et al.	2011-09-01
Methods Of Using Antibodies Against Human Il-22 App 20110091478 - Fouser; Lynette A. ; et al.	2011-04-21
Methods of using antibodies against human IL-22 Grant 7,846,444 - Fouser , et al. December 7, 2	2010-12-07
Methods of using antibodies against human IL-22 Grant 7,811,567 - Fouser , et al. October 12, 2	2010-10-12
Methods For Predicting Production Of Activating Signals By Cross-linked Binding Proteins App 20100075329 - O'Toole; Margot ; et al.	2010-03-25
Composition and method for treating lupus nephritis Grant 7,667,020 - O'Toole , et al. February 23, 2	2010-02-23
Methods of Using Antibodies Against Human IL-22 App 20100015162 - FOUSER; Lynette A. ; et al.	2010-01-21
Methods Of Treatment Utilizing Binding Proteins Of The Interleukin-21 Receptor App 20090298081 - BLOOM; Laird ; et al.	2009-12-03
Methods For Diagnosing And Treating Systemic Lupus Erythematosus Disease And Compositions Thereof App 20090263817 - O'TOOLE; Margot ; et al.	2009-10-22
Composition And Method For Treating Lupus Nephritis App 20090098132 - O'Toole; Margot ; et al.	2009-04-16
Composition and method for treating lupus nephritis Grant 7,491,513 - O'Toole , et al. February 17, 2	2009-02-17
Methods of modulating IL-22 and IL-17 App 20080031882 - Liang; Spencer C. ; et al.	2008-02-07
Composition and method for treating lupus nephritis App 20080009008 - O'Toole; Margot ; et al.	2008-01-10
Methods of using antibodies against human IL-22 App 20070258982 - Fouser; Lynette A. ; et al.	2007-11-08
Composition and method for treating lupus nephritis App 20060228356 - O'Toole; Margot ; et al.	2006-10-12
Methods for diagnosing and treating systemic lupus erythematosus disease and compositions thereof App 20060188921 - O' Toole; Margot ; et al.	2006-08-24
Composition and method for treating lupus nephritis Grant 7,060,797 - O'Toole , et al. June 13, 2	2006-06-13
Methods of identifying patients at risk of developing encephalitis following immunotherapy for Alzheimer's disease App 20060073496 - O'Toole; Margot ; et al.	2006-04-06
Enhancing immune responses with B7-1 or B7-2 in the absence of a crosslinking agent Grant 7,011,833 - Sturmhoefel , et al. March 14, 2	2006-03-14
Composition and method for treating lupus nephritis App 20050119208 - O'Toole, Margot ; et al.	2005-06-02
Composition and method for treating lupus nephritis App 20040209284 - O'Toole, Margot ; et al.	2004-10-21
Methods for diagnosing and treating systemic lupus erythematosus disease and compositions thereof App 20030148298 - O''Toole, Margot ; et al.	2003-08-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.